NCT01469325

Brief Summary

Sequential left prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS), with high frequency, for Treatment-Resistant Depression have been shown to have antidepressant effects. but doubts remain about the magnitude of previously demonstrated treatment effects.The aim of this study is To test whether daily weekday left prefrontal rTMS safely and effectively treats Resistant Depression disorder compared to sham controls.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 2, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 10, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

November 22, 2011

Status Verified

November 1, 2011

Enrollment Period

3 months

First QC Date

November 2, 2011

Last Update Submit

November 20, 2011

Conditions

Keywords

Repetitive Transcranial Magnetic StimulationDepressionleft prefrontal

Outcome Measures

Primary Outcomes (1)

  • change (decrease) of depression according to Hamilton, Beck, BPRS questionnaires.

    The primary outcome measure for the study was score on the MADRS. The patients were assessed with the MADRS, the 17-item version of the Hamilton Depression Rating Scale (HAM-D), the Beck Depression Inventory (BDI), the Brief Psychiatric Rating Scale (BPRS), the CORE Rating of Psychomotor Disturbance (16), and the Global Assessment of Functioning (GAF) Scale (DSM-IVTR).

    3 week

Study Arms (2)

Repetitive Transcranial Magnetic Stimulation

ACTIVE COMPARATOR

We deliver rTMS to the left prefrontal cortex at 120% motor threshold (10 Hz, 4-second train duration, and 26-second intertrain interval) for 37.5 minutes (3000 pulses per session) using a figure-eight solid-core coil.

Other: Repetitive Transcranial Magnetic Stimulation

Sham rTMS

SHAM COMPARATOR

Sham rTMS using a similar coil with a metal insert blocking the magnetic field and scalp electrodes that delivered matched somatosensory sensations.

Other: Sham rTMS

Interventions

We deliver rTMS to the left prefrontal cortex at 120% motor threshold (10 Hz, 4-second train duration, and 26-second intertrain interval) for 37.5 minutes (3000 pulses per session) using a figure-eight solid-core coil

Repetitive Transcranial Magnetic Stimulation

Sham rTMS using a similar coil with a metal insert blocking the magnetic field and scalp electrodes that delivered matched somatosensory sensations.

Sham rTMS

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-IV diagnosis of major depression
  • Resistance to treatment as defined by the insufficient clinical benefit to at least one adequate medication trials

You may not qualify if:

  • Other current Axis I disorders (except simple phobia and nicotine addiction)
  • Personal or close family history of seizure disorder
  • Ferromagnetic material in body or close to head
  • Neurologic disorder
  • Pregnancy
  • Taking medications known to lower seizure threshold (eg, theophylline)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iranian National Center for Addiction Studies

Tehran, Tehran Province, Iran

Location

MeSH Terms

Conditions

Depression

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Central Study Contacts

Javad Alaghband-rad, Associate Professor

CONTACT

Zahra Khazaeipour, Community Medicin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 2, 2011

First Posted

November 10, 2011

Study Start

November 1, 2011

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

November 22, 2011

Record last verified: 2011-11

Locations